50 /100
MEDIUM RISK
Score updated Jul 13, 2026

AGEN — Agenus Inc. Dilution Risk Tracker

Track AGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGEN — Get alerts when the score changes →

As of July 13, 2026, Agenus Inc. (AGEN) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Agenus Inc. has a market capitalization of $145.75M, 41.64M shares outstanding, 90 institutional holders tracked. Key dilution vectors include 675.0K outstanding warrants, approximately 4 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
22%
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
🔄 Reverse Split 15%
• Only 4 months cash — financial pressure
🔔 Track AGEN — Get forecast alerts →

💹 Market Data

Market Cap$145.75M
Shares Outstanding41.64M
Float38.63M
Cash$49.64M
Debt$30.19M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.7% shares (2026Q1 vs prior)
90 institutional holders · 12.05M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.88M shares
#2 VANGUARD PORTFOLIO MANAGEMENT LLC 1.20M shares
#3 MORGAN STANLEY 1.13M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.99M
Days to Cover5.4
% of Float15.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Apr 06, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 24, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for AGEN Shareholders

Agenus Inc. (AGEN) has a DilutionScore of 50/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch tracks 675,000 outstanding warrants for AGEN. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: AGEN has approximately 4 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for AGEN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for AGEN alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track AGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for AGEN
📊 AGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AGEN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.